Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Taho Pharmaceuticals

Status
Global HQ
Taipei, Taiwan
Countries of investment
    Investment stages
      Industries
        About
        Taho Pharmaceuticals 泰合生技藥品股份有限公司 is a pioneering biotech firm dedicated to the innovative development of novel therapeutics targeting niche medical markets. With a robust portfolio of self-developed products addressing conditions such as schizophrenia, attention deficit hyperactivity disorder (ADHD), and chemotherapy-induced nausea, the company has successfully secured clinical trial permits and patents in the United States. Taho Pharmaceuticals is committed to advancing healthcare solutions through rigorous research and development, aiming to enhance the quality of life for patients with unmet medical needs. Their strategic focus on specialized therapies positions them as a leader in the biotech landscape, driving progress and innovation within the industry.
        Min check size
        -
        Max check size
        -
        Fund size
        NPS

        Investment Thesis

        Lead investor
        Co Invest
        Number of exits
        Preferred contact method

        Taho Pharmaceuticals Contacts Information

        Fund number
        Vintage Year
        Net Internal Rate of Return
        Investment Multiple
        Capital Allocation
        Management Fee
        Carried Interest
        AUM
        Follow-on Investments
        Graduation Rate
        Write-Off Ratio
        Last profile update timestamp